商务合作
动脉网APP
可切换为仅中文
The VO1 arthroscopic surgical robot. [Image courtesy of Convergence Medical]
VO1关节镜手术机器人。[图片由Convergence Medical提供]
Australian medtech company Convergence Medical recently brought in about $3.1 million (AU$5 million) to support its surgical robot.
澳大利亚医疗技术公司Convergence Medical最近投入了约310万美元(500万澳元)来支持其手术机器人。
The Brisbane-based company touts its VO1 robot as the world’s first arthroscopic surgical robot. VO1 won FDA breakthrough device designation in December 2023.
这家总部位于布里斯班的公司吹嘘其VO1机器人是世界上第一个关节镜手术机器人。VO1于2023年12月获得FDA突破性设备称号。
Global investors — including U.S.-based Avicella Capital — provided the funding that closes out the company’s Series A round. Convergence Medical plans to use the funds to support commercialization, expand into the U.S. and penetrate the global arthroscopic industry.
包括总部位于美国的Avicella Capital在内的全球投资者为该公司的A轮融资提供了资金。Convergence Medical计划使用这些资金支持商业化,扩展到美国并渗透到全球关节镜行业。
According to a news release, the funding elevates the company’s value to more than $18.7 million (AU$30 million). This sets the stage for expansion and delivers a return on investment for investors who backed the company since its inception three years ago.
根据一份新闻稿,这笔资金将该公司的价值提升至1870多万美元(3000万澳元)。这为公司的扩张奠定了基础,并为自三年前成立以来一直支持该公司的投资者带来了投资回报。
The company plans to direct funds toward scaling production, expanding global partnerships and advancing R&D efforts. It anticipates a soft launch of VO1 “soon.”
该公司计划将资金用于扩大生产规模、扩大全球合作伙伴关系和推进研发工作。它预计VO1将“很快”软启动
“We’re thrilled to achieve this important milestone in our journey to commercialization and excited to be working with Avicella Capital, who are seasoned investors with a great track record in the global MedTech industry,” said Dr. Chris Jeffery, founder and CEO of Convergence Medical. “This funding enables us to accelerate our growth and bring our transformative technology to hospitals and surgeons around the globe.
Convergence Medical创始人兼首席执行官克里斯·杰弗里(ChrisJeffery)博士表示:“我们很高兴在商业化进程中取得这一重要里程碑,也很高兴能与阿维塞拉资本(Avicella Capital)合作,阿维塞拉资本是经验丰富的投资者,在全球医疗技术行业拥有良好的业绩记录。”。“这笔资金使我们能够加速增长,并将我们的变革性技术带给全球的医院和外科医生。
Our mission is to create more efficient, effective solutions that support medical professionals and improve patient outcomes worldwide.”.
我们的使命是创造更高效、更有效的解决方案,为医疗专业人员提供支持,并改善全球患者的预后。”。